5 Key Takeaways

• 1

  Delays in patient diagnosis can extend to years, impacting timely access to precision therapies designed for specific conditions.

• 2

  Current commercial strategies focus on reaching physicians, neglecting the patient journey that precedes diagnosis.

• 3

  Precision medicine requires a shift in commercial operations to understand patient trajectories rather than solely physician profiles.

• 4

  Every year a patient spends undiagnosed can lead to disease progression and reduced treatment options, highlighting the urgency of timely diagnosis.

• 5

  Improving the connection between patient needs and commercial strategies is essential to enhance the effectiveness of precision therapies.